Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04952376 · ClinicalTrials.gov registry record · NA
Equitable Access to COVID-19 Vaccines
A NA study of Covid19, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 1,722
- Enrollment target
- 1
- Study location
NCT04952376 is a NA study of Covid19 that has completed, run by Mayo Clinic. The registered enrollment target is 1,722 participants, below the 2,684-participant average among 94 other Covid19 trials with a reported enrollment target (36% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04952376, a NA study of Covid19, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,722 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will deploy a multimodal pragmatic intervention to improve vaccine uptake in priority populations and address vaccine hesitancy to improve access by using a proactive organized population-based outreach leveraging health information technology with tailored navigation support to address mistrust and social barriers.
Conditions Studied
Interventions
- BEHAVIORAL SMS delivery of information
- BEHAVIORAL Personalized text message delivery of information
- BEHAVIORAL Interactive or 2-way SMS delivery of information
Study Locations (1)
Arizona
- Mayo Clinic - Scottsdale
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,722 participants |
| Start Date | 2021-04-01 |
| Est. Completion | 2021-06-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04952376
The ClinicalTrials.gov registry entry for NCT04952376 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 1,722 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,684-participant average among 94 other Covid19 trials with a reported enrollment target (36% lower). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Covid19 appearing as the primary indexed condition, and to 3 interventions - of which SMS delivery of information is the first listed.
NCT04952376 reports 1 study location spanning 1 distinct geographic area - top geographies include Arizona.
Frequently Asked Questions
What is clinical trial NCT04952376 about?
NCT04952376 is a clinical study titled "Equitable Access to COVID-19 Vaccines". This study will deploy a multimodal pragmatic intervention to improve vaccine uptake in priority populations and address vaccine hesitancy to improve access by using a proactive organized population-based outreach leveraging health information technology with tailored navigation support to address m...
What is the current status of trial NCT04952376?
This trial is currently completed. It is a NA study. The enrollment target is 1,722 participants. The study started on 2021-04-01. Estimated completion is 2021-06-10.
What conditions does trial NCT04952376 study?
This clinical trial studies the following conditions: Covid19.
What interventions are being tested in trial NCT04952376?
The interventions under investigation include: SMS delivery of information (BEHAVIORAL), Personalized text message delivery of information (BEHAVIORAL), Interactive or 2-way SMS delivery of information (BEHAVIORAL).
Who is sponsoring clinical trial NCT04952376?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04952376 being conducted?
This trial has 1 study location across Arizona. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Covid19
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Multimodal Parent-focused Intervention for Vulnerable Populations in the Bronx
RECRUITING · NA
-
Improving Health Equity for COVID-19 Vaccination for At-risk Populations Using Online Social Networks
ACTIVE NOT RECRUITING · NA
-
Community Developed Technology-Based Messaging to Increase COVID-19 Vaccine Uptake Among People Who Inject Drugs
ACTIVE NOT RECRUITING · NA
-
A Study To Evaluate The Performance of the Lucira Health All-In-One COVID-19 Test Kit vs Hologic Panther Fusion
COMPLETED · NA
-
Implementation of COVID-19 Testing Strategies in Community Health Centers
COMPLETED · NA
-
Minnesota COVID-19 Testing Project
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.